** Shares of vaccine maker Novavax NVAX.O gain 4.6% to $8.80 premarket
** NVAX to sell its Czech Republic manufacturing facility to Novo Nordisk NOVOb.CO for $200 mln, co says
** NVAX expects to reduce annual operating costs by ~$80 mln
** The deal expected to close by Dec. 30
** NOVO up 0.5% at $109.73 premarket
** 3 of 6 brokerages rate NVAX "buy" or higher, 2 "hold" and 1 "sell"; their median PT is $19 - LSEG
** As of last close, NVAX has risen 75.2% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.